Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000899032 | SCV001043274 | likely benign | not provided | 2024-03-17 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002502643 | SCV002813771 | likely benign | Autosomal dominant Alport syndrome; Autosomal recessive Alport syndrome; Benign familial hematuria | 2021-09-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004973144 | SCV005568993 | likely benign | Inborn genetic diseases | 2024-08-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000899032 | SCV005626617 | uncertain significance | not provided | 2024-07-08 | criteria provided, single submitter | clinical testing | In silico analysis indicates that this variant does not alter splicing; Has not been previously published as pathogenic or benign to our knowledge |
Natera, |
RCV001274579 | SCV001458836 | uncertain significance | Alport syndrome | 2020-01-24 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000899032 | SCV001928074 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000899032 | SCV001953538 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000899032 | SCV001970571 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003975707 | SCV004788972 | likely benign | COL4A3-related disorder | 2022-12-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |